Funds holding XILIO THERAPEUTICS INC
ISIN US98422T1007 · United States
- Fund holders
- 0
No tracked fund declares this company in its latest report.
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 4 | -4 | 269,003 | -81.0 % |
| 2026Q1 | 8 | 0 | 1,418,137 | -2.9 % |
| 2025Q4 | 8 | +1 | 1,461,232 | -4.3 % |
| 2025Q3 | 7 | -2 | 1,527,266 | -3.8 % |
| 2025Q2 | 9 | 0 | 1,588,155 | +17.7 % |
| 2025Q1 | 9 | 0 | 1,349,277 | +11.1 % |
| 2024Q4 | 9 | -2 | 1,214,426 | +9.8 % |
| 2024Q3 | 11 | +1 | 1,105,750 | +0.4 % |
| 2024Q2 | 10 | -2 | 1,101,289 | -7.3 % |
| 2024Q1 | 12 | -4 | 1,188,174 | +3.3 % |
| 2023Q4 | 16 | 1,150,403 |
Institutional managers
1 manager declares this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| GILEAD SCIENCES, INC. | 650,389 | 5.5M $ | as of Mar 31, 2026 |
Cite this page
Titelia. "Funds holding XILIO THERAPEUTICS INC". https://titelia.com/en/stocks/xilio-therapeutics-inc-US98422T1007